SpyGlass Pharma, Inc. cotiza a 23.92 USD y tiene una capitalización bursátil de $800M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is de…
| Periodo | 2026-11 | 2026-08 | 2026-05 |
|---|---|---|---|
| Real | — | $-0.59 | $-0.69 |
| Estimado | $-0.62 | $-0.55 | $-0.36 |
| Sorpresa | — | -7.3% | -91.7% |
| Métrica | SGP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -34.4% | -32.0% | -2.4% |
| Current Ratio | 12.67 | 2.84 | +9.83 |
| Debt / Equity | — | 0.28 | — |